SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-069337
Filing Date
2021-05-19
Accepted
2021-05-19 16:15:55
Documents
14
Period of Report
2021-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115448d3_8k.htm   iXBRL 8-K 26380
2 EXHIBIT 99.1 tm2115448d3_ex99-1.htm EX-99.1 17968
6 GRAPHIC tm2115448d3_ex99-1img001.jpg GRAPHIC 4320
  Complete submission text file 0001104659-21-069337.txt   230390

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ymab-20210519.xsd EX-101.SCH 3178
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymab-20210519_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymab-20210519_pre.xml EX-101.PRE 22705
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2115448d3_8k_htm.xml XML 3600
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 21940473
SIC: 2834 Pharmaceutical Preparations